BARTOLUCCI, GIAN LUCA
 Distribuzione geografica
Continente #
NA - Nord America 17.659
EU - Europa 11.574
AS - Asia 8.681
SA - Sud America 1.133
AF - Africa 236
OC - Oceania 135
Continente sconosciuto - Info sul continente non disponibili 4
Totale 39.422
Nazione #
US - Stati Uniti d'America 17.440
RU - Federazione Russa 3.703
IT - Italia 2.949
SG - Singapore 2.496
CN - Cina 2.143
PL - Polonia 1.320
HK - Hong Kong 1.239
BR - Brasile 879
VN - Vietnam 783
IE - Irlanda 773
KR - Corea 719
SE - Svezia 669
DE - Germania 492
FR - Francia 384
FI - Finlandia 363
IN - India 321
GB - Regno Unito 260
BD - Bangladesh 214
AU - Australia 128
JP - Giappone 128
ID - Indonesia 127
UA - Ucraina 127
CA - Canada 124
NL - Olanda 117
JO - Giordania 114
AR - Argentina 96
TR - Turchia 93
CH - Svizzera 92
ES - Italia 86
BE - Belgio 59
ZA - Sudafrica 57
MX - Messico 54
DK - Danimarca 49
EC - Ecuador 43
IQ - Iraq 42
CO - Colombia 35
CI - Costa d'Avorio 34
NG - Nigeria 33
PK - Pakistan 28
VE - Venezuela 24
PH - Filippine 23
TW - Taiwan 23
UZ - Uzbekistan 23
CL - Cile 21
SA - Arabia Saudita 21
EG - Egitto 20
LT - Lituania 19
MA - Marocco 18
CZ - Repubblica Ceca 16
KE - Kenya 16
RO - Romania 16
IL - Israele 15
AT - Austria 14
DZ - Algeria 14
MY - Malesia 14
NP - Nepal 14
PY - Paraguay 14
TH - Thailandia 14
AL - Albania 11
AE - Emirati Arabi Uniti 10
PT - Portogallo 10
BJ - Benin 9
BG - Bulgaria 8
KG - Kirghizistan 8
KZ - Kazakistan 8
TN - Tunisia 8
CR - Costa Rica 7
IR - Iran 7
NZ - Nuova Zelanda 7
PE - Perù 7
QA - Qatar 7
SN - Senegal 7
AZ - Azerbaigian 6
BH - Bahrain 6
BO - Bolivia 6
LB - Libano 6
LV - Lettonia 6
RS - Serbia 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
JM - Giamaica 5
NI - Nicaragua 5
NO - Norvegia 5
BB - Barbados 4
HU - Ungheria 4
MM - Myanmar 4
MO - Macao, regione amministrativa speciale della Cina 4
OM - Oman 4
TT - Trinidad e Tobago 4
HN - Honduras 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CG - Congo 2
CY - Cipro 2
EE - Estonia 2
Totale 39.379
Città #
Santa Clara 3.584
Ashburn 2.298
Singapore 1.857
Warsaw 1.312
Fairfield 1.215
Hong Kong 1.058
Chandler 822
Dublin 764
San Jose 694
Seoul 672
Woodbridge 601
Seattle 533
Houston 514
Hefei 493
Cambridge 476
Florence 446
Milan 405
Wilmington 404
Beijing 391
Ann Arbor 296
Los Angeles 295
Ho Chi Minh City 269
Munich 268
Council Bluffs 248
The Dalles 244
Rome 230
Buffalo 216
Lawrence 213
Altamura 210
Dallas 209
Princeton 194
Lauterbourg 192
Jacksonville 188
Helsinki 174
Hanoi 171
Moscow 160
New York 142
Mumbai 135
Boardman 131
Boston 128
Tokyo 117
Melbourne 112
Shanghai 97
Medford 94
Kent 93
San Diego 86
Paris 84
Jakarta 81
Clifton 75
São Paulo 75
Bern 70
Chicago 64
Turku 64
Bologna 59
London 56
Naples 51
Turin 49
Orem 48
Redondo Beach 47
Brussels 44
Lappeenranta 42
Guangzhou 40
Phoenix 40
Bengaluru 38
Pune 38
Frankfurt am Main 36
Porto Alegre 36
Abidjan 34
Atlanta 34
Figino 34
Toronto 33
Chennai 32
Johannesburg 32
San Francisco 32
Abuja 31
Izmir 31
Gavirate 30
Montreal 30
Haiphong 29
Hillsboro 29
Salt Lake City 29
Barcelona 28
Da Nang 28
Brooklyn 27
Dong Ket 26
Denver 25
Miano 25
Norwalk 25
Genoa 23
Hangzhou 23
Bari 22
Falls Church 22
Redwood City 22
Belo Horizonte 21
Copenhagen 21
Tashkent 21
Verona 21
Rio de Janeiro 20
Amsterdam 19
Brasília 19
Totale 25.466
Nome #
Effects of the probiotic Lactiplantibacillus plantarum IMC 510® on body composition, biochemical parameters, gut microbiota composition and function, and clinical symptoms of overweight/obese subjects 728
Gonadotropin-releasing hormone modulates cholesterol synthesis and steroidogenesis in SH-SY5Y cells. 402
Dominulin A and B: two new antibacterial peptides identified on the cuticle and in the venom of the social paper wasp Polistes dominulus using MALDI-TOF, MALDI-TOF/TOF, and ESI-ion trap. 380
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists 344
Oleuropein-rich leaf extract affects intestinal microbiota and free fatty acids in Apc-mutant and wt rats 341
Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression 330
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors 323
CHINESE ASTRAGALUS ROOT EXTRACTS: A CASE STUDY 316
New Histamine-Related Five-Membered N-Heterocycle Derivatives as Carbonic Anhydrase I Activators 308
Synthesis of 5,6,6-[2H3]finasteride and quantitative determination of finasteride in human plasma at picogram level by an isotope-dilution mass spectrometric method. 291
2-Benzylpiperazine: a new scaffold for potent human Carbonic Anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents. 277
Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers 273
Isotopic dilution GC-MS measurement of 4-Hydroxyandrostendione in postmenopausal breast cancer 268
Evaluation and comparison of short chain fatty acids composition in gut diseases 265
QUANTITATIVE ANALYSIS OF LACTOYLGLUTATHIONE: A NEW 2D-HPLC-MS/MS APPROACH WITHOUT ION-PAIR AGENTS 264
Synthesis, enantioresolution and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. 264
4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced anti-proliferative profiles. 260
Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence 256
Gut microbiota metabolites mediate the interplay between childhood maltreatment and psychopathology in patients with eating disorders 245
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug-resistance (MDR) modulators 244
2-Butyl-4-oxo-3-([2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl)-3-aza-1-azoniaspiro[4.4]non-1-ene chloride 1.69-hydrate (irbesartan hydrochloride 1.69-hydrate) 243
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 243
Characterization of the volatile profile of Antarctic bacteria by using solid-phase microextraction-gas chromatography-mass spectrometry 241
6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers 236
Metformin reacts directly with glucose following the Maillard reaction pathway 233
Similar but Different: The Case of Metoprolol Tartrate and Succinate Salts 231
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters 230
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 228
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 227
2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and antiglaucoma activity 224
Development of a method for the quantification of estrone and estradiol in serum by LC-MS/MS 224
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors 223
Corso di formazione specialistica. L'accoppiamento cromatografia liquida ad alte prestazioni-spettrometria di massa (HPLC-MS): principi e applicazioni 221
Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents 214
A CONVENIENT ROUTE TO THE SYNTHESIS OF ISOTOPOMERIC DIHYDRO-2(3H)FURANONES 212
Dual P-glycoprotein and CA XII inhibitors: A new strategy to reverse the P-gp Mediated Multidrug Resistance (MDR) in cancer cells y 212
Synthesis and carbonic anhydrase activating properties of a series of 2-amino-imidazolines structurally related to clonidine 211
Energy resolved tandem mass spectrometry experiments for resolution of isobaric compounds: a case of cis/trans isomerism 211
Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites 210
Discovery of New Selenoureido Analogues of 4-(4-Fluorophenylureido)benzenesulfonamide as Carbonic Anhydrase Inhibitors 209
Disodium 2,2'-dithiobis(ethanesulfonate) trihydrate (dimesna trihydrate) 208
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 207
Diisopropyl[2-[2-(2-oxopyrrolidin-1-yl)acetamido]ethyl]ammonium hydrogen sulfate 206
Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. 205
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity 203
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 202
Development of a HPLC-MS/MS method for the pharmacokinetic studies of Pirfenidone in pig plasma 202
4-Amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide 201
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors 201
Vitamin D3 quantification in a cod liver oil-based supplement 200
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 199
A MULTI-DISEASE STATISTICAL ANALYSIS OF FREE FATTY ACID SIGNATURES ASSESSED BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY 197
3-Methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl 4-aminobenzoate 197
Antarctic bacteria as producers of antibiotic volatile compounds inhibiting cystic fibrosis pathogens 197
Aminoarylesters as multidrug resistance (MDR) reverting agents endowed with high potency and efficacy 197
Effect of ancient wheat pasta on gut microbiota composition and bacteria-derived metabolites: A randomized controlled trial 196
Sponge-associated microbial Antarctic communities exhibiting antimicrobial activity against Burkholderia cepacia complex bacteria 196
Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis 196
Oral and fecal microbiota perturbance in cocaine users: Can rTMS-induced cocaine abstinence support eubiosis restoration? 195
Characterization of the "gut microbiota-immunity axis" and microbial lipid metabolites in atrophic and potential celiac disease 195
Combining liquid chromatography and tandem mass spectrometry approaches to the study of monoterpene glycosides (Aroma precursors) in wine grape 195
Liquid chromatography tandem mass spectrometric quantitation of sulfamethazine and its metabolites: direct analysis of swine urine by triple quadrupole and by ion trap mass spectrometry. 194
A validated HPLC stability-indicating method for the determination of diacerhein in bulk drug substance 194
Monitoring of air-dispersed formaldehyde and carbonyl compounds as vapors and adsorbed on particulate matter by denuder-filter sampling and gas chromatographic analysis 194
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring 193
Vaginal lactobacilli and vaginal dysbiosis-associated bacteria differently affect cervical epithelial and immune homeostasis and anti-viral defenses 193
Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII 192
Aromatic sulfonamides including a sulfonic acid tail: New membrane impermeant carbonic anhydrase inhibitors for targeting selectively the cancer‐associated isoforms 192
GC-MS Volatolomic Approach to Study the Antimicrobial Activity of the Antarctic Bacterium Pseudoalteromonas sp. TB41 191
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 191
Bioactive volatile organic compounds from Antarctic (sponges) bacteria 190
In Vitro Evidence for the Use of Astragali Radix Extracts as Adjuvant against Oxaliplatin-Induced Neurotoxicity 185
Design, Synthesis and Pharmacological Evaluation of New Quinoline-Based Panx-1 Channel Blockers 184
Changes in faecal microbiota profile and plasma biomarkers following the administration of an antioxidant oleuropein-rich leaf extract in a rat model mimicking colorectal cancer 184
Effects of Ultramicronized N-Palmitoylethanolamine Supplementation on Tramadol and Oxycodone Analgesia and Tolerance Prevention 184
Selective determination of aloin in different matrices by HPTLC densitometry in fluorescence mode 183
ERMS EXPERIMENTS FOR RESOLUTION OF ISOBARIC COMPOUNDS: A CASE OF CIS/TRANS ISOMERISM 183
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 182
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 182
Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents 182
2- or 3-Substituted piperazines as nootropic agents: carbethoxy and hydroxymethyl analogues of the cognition-enhancer DM235 182
Oli essenziali: analisi e caratterizzazione mediante GC-MS e GC-MS/MS 182
New dual P-Glycoprotein (P-gp) and human carbonic anhydrase XII (hCA XII) inhibitors as Multidrug Resistance (MDR) reversers in cancer cells 180
Sample Preparation for Direct MS Analysis of Food 180
Bioisosteric Development of Multitarget Nonsteroidal Anti-Inflammatory Drug-Carbonic Anhydrases Inhibitor Hybrids for the Management of Rheumatoid Arthritis 179
Rapid quantitation of globotriaosylceramide in human plasma and urine: a potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease 178
Antarctic sponge bacteria: a new potential source of natural antibiotic compounds 178
SERS detection of benzophenones on viologen functionalized Ag nanoparticles: application to breakfast cereals 178
Discovery of New Sulfonamide Carbonic Anhydrase IX Inhibitors Incorporating Nitrogenous Bases 178
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in Tissues 178
N-alkanol-N-cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacy 177
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 176
Development and validation of a quantitative spectrophotometric method to detect the amount of carbon monoxide in treated tuna fish. 176
METABOLIC SYNDROME-ASSOCIATED SPERM ALTERATIONS IN AN EXPERIMENTAL RABBIT MODEL: RELATION WITH METABOLIC PROFILE, TESTIS AND EPIDIDYMIS GENE EXPRESSION AND EFFECT OF TAMOXIFEN TREATMENT 176
Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis 176
Thermalisation in CID MS/MS on a QqQ: towards ion trap CID excitation conditions ? 175
New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3∗ Nicotinic Receptors 175
Azidothymidine "clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors 174
Solid-state study of mepivacaine hydrochloride 173
Isomers Recognition in HPLC-MS/MS Analysis of Human Plasma Samples by Using an Ion Trap Supported by a Linear Equations-Based Algorithm 172
Totale 22.173
Categoria #
all - tutte 110.085
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.085


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021123 0 0 0 0 0 0 0 0 0 0 0 123
2021/20221.310 34 118 122 49 24 53 110 87 57 62 251 343
2022/20233.665 321 711 207 233 270 601 438 213 365 36 134 136
2023/20241.699 66 154 225 95 128 223 68 296 59 103 141 141
2024/202511.455 367 1.067 702 1.604 2.937 1.570 372 633 679 335 609 580
2025/202614.804 1.500 1.747 1.204 1.260 1.543 605 1.739 710 947 908 542 2.099
Totale 39.855